VIRTUALMAN

Biotechnology Research • 3F., No. 196, Taiwan, Province of China • 1-10 Employees

Company overview

Headquarters	3F., No. 196, Sec. 2, Fuxing S. Rd., Da’an Dist., Taipei City, 106, TW
Website	virtualman.ai
NAICS	541714
Keywords	Drug Development, Computational Chemistry, In Silico Testing, Ai-Driven Drug Development
Employees	1-10
Socials

Key Contacts at VIRTUALMAN

Xin Liu

Co-Founder

Tung-Sheng Cho

Co-Founder & Head Of Product Development

About VIRTUALMAN

VIRTUALMAN predicts experimental results with clear optimization guidelines in the pre-clinical drug development phase. Our service combines pharmaceutical expertise with prediction models. We commit to accelerating drug development. With the latest ADDD (AI-Driven Drug Development) platform, powered by the revolutionary Explainable AI models, we support pharmaceutical chemists to succeed down the road through multi-parameter optimization. VIRTUALMAN works closely with pharmaceutical companies. Join VIRTUALMAN to facilitate drug development that brings a brighter future.

VIRTUALMAN revenue & valuation

Annual revenue	$598,885
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,000,000
Total funding	No funding